Your browser doesn't support javascript.
loading
Dexamethasone differentially depletes tumour and peripheral blood lymphocytes and can impact the efficacy of chemotherapy/checkpoint blockade combination treatment.
Aston, Wayne J; Hope, Danika E; Cook, Alistair M; Boon, Louis; Dick, Ian; Nowak, Anna K; Lake, Richard A; Lesterhuis, W Joost.
Afiliação
  • Aston WJ; National Centre for Asbestos Related Diseases, The University of Western Australia, Nedlands, WA, Australia.
  • Hope DE; Medical School, The University of Western Australia, Nedlands, WA, Australia.
  • Cook AM; National Centre for Asbestos Related Diseases, The University of Western Australia, Nedlands, WA, Australia.
  • Boon L; School of Biomedical Sciences, The University of Western Australia, Nedlands, WA, Australia.
  • Dick I; National Centre for Asbestos Related Diseases, The University of Western Australia, Nedlands, WA, Australia.
  • Nowak AK; Medical School, The University of Western Australia, Nedlands, WA, Australia.
  • Lake RA; Bioceros, Utrecht, The Netherlands.
  • Lesterhuis WJ; National Centre for Asbestos Related Diseases, The University of Western Australia, Nedlands, WA, Australia.
Oncoimmunology ; 8(11): e1641390, 2019.
Article em En | MEDLINE | ID: mdl-31646089

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2019 Tipo de documento: Article